February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...
April 16, 2025 
April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...
April 11, 2025 
April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...
April 10, 2025 
March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...
April 02, 2025 
March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...
March 21, 2025 
March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...
March 19, 2025 
Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...
March 03, 2025 
Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...
January 27, 2025 
Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...
January 14, 2025 
Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...
January 08, 2025